1 – 16 of 16
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Glucagon dynamics during hypoglycaemia and food-re-challenge following treatment with vildagliptin in insulin-treated patients with type 2 diabetes.
(
- Contribution to journal › Article
- 2013
-
Mark
Enhanced beta cell function and anti-inflammatory effect after chronic treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin in an advanced-aged diet-induced obesity mouse model.
(
- Contribution to journal › Article
- 2011
-
Mark
Clinical evidence and mechanistic basis for vildagliptin's action when added to metformin.
(
- Contribution to journal › Article
-
Mark
Mechanisms of Action of the DPP-4 Inhibitor Vildagliptin in Man.
(
- Contribution to journal › Scientific review
- 2010
-
Mark
Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study
(
- Contribution to journal › Article
- 2009
-
Mark
Vildagliptin improves glucose sensitivity of cells in patients with type 2 diabetes: glucagon response to hypoglycemia
(
- Contribution to journal › Published meeting abstract
-
Mark
Changes in prandial glucagon levels after 2 years treatment with vildagliptin or glimepiride
2009) 45th Annual Meeting of the European-Association-for-the-Study-of-Diabetes In Diabetologia 52(Suppl 1). p.798-798(
- Contribution to journal › Published meeting abstract
- 2008
-
Mark
The islet enhancer vildagliptin: mechanisms of improved glucose metabolism.
(
- Contribution to journal › Article
-
Mark
Vildagliptin improves alpha cell glucose sensing in patients with type 2 diabetes
2008) 44th EASD Annual Meeting of the European Association for the Study of Diabetes In Diabetologia 51(S1). p.36-37(
- Contribution to journal › Published meeting abstract
-
Mark
Efficacy and tolerability of vildagliptin in drug-naive patients with type 2 diabetes and mild hyperglycaemia
(
- Contribution to journal › Article
-
Mark
Evidence that vildagliptin attenuates deterioration of glycaemic control during 2-year treatment of patients with type 2 diabetes and mild hyperglycaemia
(
- Contribution to journal › Article
-
Mark
Effects of the DPP-4 Inhibitor Vildagliptin on Incretin Hormones, Islet Function, and Postprandial Glycemia in Subjects with Impaired Glucose Tolerance
(
- Contribution to journal › Article
- 2007
-
Mark
Improved meal-related insulin processing contributes to the enhancement of B-Cell function by the DPP-4 inhibitor vildagliptin in patients with type 2 diabetes
(
- Contribution to journal › Article
- 2006
-
Mark
Climate and air quality
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2005
-
Mark
Alpha cell function in health and disease: influence of glucagon-like peptide-1
(
- Contribution to journal › Scientific review
- 2001
-
Mark
Carbon Cycle Model Linkage Project (CCMLP): Evaluating Biogeochemical Process Models with Atmospheric Measurements and Field Experiments
2001) American Geophysical Union, fall meeting(
- Contribution to conference › Abstract